Pain Points

Operators confuse pulsed RF​ and continuous thermal RF. Pulsed = neuromodulation, low temperature, no destructive lesion. Thermal = coagulation lesion, 60–80°C+. Use pulsed where you want to calm the nerve; use thermal where you want to lesion it.

The wrong choice causes a cascade of problems. If the operator uses thermal RF on a nerve that should have been treated with pulsed RF, the result is motor nerve injury, weakness, or paralysis. If the operator uses pulsed RF on a nerve that should have been treated with thermal RF, the result is inadequate relief, and the patient remains in pain.

The consequences are severe. A motor nerve injury can be permanent. The patient may lose function in a limb, may require additional surgery, and may face a lifetime of disability. The physician faces a lawsuit, a loss of reputation, and a loss of confidence. The hospital bears the cost of the complication and the potential liability.

Other pain points include:

The operator may not understand the difference between the two modes. They may think that "RF is RF" and that the mode does not matter.

The operator may not have the right needle. Some needles are designed for pulsed RF, with a specific insulation and tip geometry. Others are designed for thermal RF.

The operator may not have the right generator. Some generators are designed for pulsed RF, with a specific pulse pattern and temperature cap. Others are designed for thermal RF.

The operator may not perform the stimulation test. The stimulation test is essential for confirming the target and for determining the appropriate mode.

Principle

Both pulsed RF and thermal RF use a 22G RF needle as the current path. The difference is in the energy delivery.

Thermal RF delivers continuous energy, raising the tissue temperature to 60–80°C. The heat denatures proteins, creating a lesion in the tissue. The lesion interrupts the pain signal, providing relief. Thermal RF is destructive; it destroys the nerve or the tissue.

Pulsed RF delivers energy in short bursts, with cooling intervals between bursts. The tissue temperature is maintained below 42°C, which is below the threshold for protein denaturation. The mechanism of action is not thermal destruction but rather electrical field modulation. The pulsed RF changes the electrical environment around the nerve, modulating the inflammatory response and the nerve's ability to transmit pain signals.

The choice of mode depends on the clinical application. Thermal RF is used for denervation, where the goal is to destroy the nerve. Pulsed RF is used for neuromodulation, where the goal is to calm the nerve without destroying it.

The physics is still ionic friction, but the application is different. In thermal RF, the ionic friction is continuous, generating sustained heat. In pulsed RF, the ionic friction is intermittent, generating brief bursts of heat that are dissipated during the cooling intervals.

Device Types

Several types of 22G disposable RF needles are available for pulsed and thermal RF.

22G Pulsed RF Needle​ is designed for pulsed RF. The needle has a specific insulation and tip geometry that is optimized for pulsed energy delivery. The needle is compatible with generators that have a pulsed RF mode.

22G Continuous RF Needle​ is designed for thermal RF. The needle has a specific insulation and tip geometry that is optimized for continuous energy delivery. The needle is compatible with generators that have a continuous RF mode.

22G Thermocouple Needle​ incorporates a thermocouple at the tip. The thermocouple measures the tissue temperature in real time and transmits the data to the generator. The generator uses this feedback to adjust the energy delivery, maintaining the target temperature.

22G Dual-Mode Needle​ is designed for both pulsed and thermal RF. The needle is compatible with generators that have both modes. The operator can switch between modes during the procedure.

22G Stimulation-Integrated Needle​ incorporates a stimulation electrode. The operator can perform sensory and motor stimulation testing before delivering RF energy. This reduces the risk of motor nerve injury.

Hands-on Guide

The following steps represent best practice for using a 22G disposable RF needle for pulsed and thermal RF.

Step 1: Determine the Clinical Goal.​ The operator should determine whether the goal is denervation or neuromodulation. For denervation, use thermal RF. For neuromodulation, use pulsed RF.

Step 2: Perform Stimulation Testing.​ Before delivering RF energy, the operator should stimulate the nerve to confirm the target. A sensory response in the dermatome confirms that the needle is near the nerve. A motor response at a low threshold indicates that the needle is too close to a motor nerve.

Step 3: Select the Appropriate Mode.​ For thermal RF, use continuous energy at 60–80°C for 60–90 seconds. For pulsed RF, use pulsed energy at 42°C for 120 seconds per cycle.

Step 4: Monitor Temperature and Impedance.​ The operator should monitor the temperature and impedance throughout the procedure. A sudden increase in impedance may indicate charring or gas formation.

Step 5: Document the Procedure.​ The operator should document the mode, the temperature, the impedance, the time, and the patient's response.

Field Experience

Clinics using pulsed RF for post-discectomy syndrome get modest but durable relief. The pulsed RF modulates the nerve without destroying it, providing relief without the risk of motor nerve injury.

Thermal RF for facet joints has more robust evidence in interventional pain. The thermal lesion interrupts the pain signal, providing longer-lasting relief. The key is to place the lesion accurately and to protect the motor nerve.

One important lesson from the field: the stimulation test is the most important step. The operator must take the time to perform the test carefully and to interpret the patient's response accurately. A poorly performed stimulation test can lead to a misplaced lesion and a poor outcome.

Summary

Pulsed RF is "talk to the nerve." Thermal RF is "reset the nerve." The 22G needle makes both minimally traumatic. The choice of mode depends on the clinical goal, and the operator must understand the difference between the two.

The result is a procedure that is tailored to the patient's needs. The operator can choose the mode that is most appropriate for the clinical scenario, providing the best possible outcome.

Outlook and Recommendations

The future of pulsed and thermal RF will be shaped by advances in generator technology and needle design.

Biomarker-Guided Mode Selection.​ Future protocols will use inflammatory biomarkers, such as CRP and IL-6, to determine the appropriate mode. A high inflammatory burden may predict a better response to pulsed RF.

Closed-Loop Temperature Control.​ Future generators will incorporate closed-loop temperature control, automatically adjusting the energy delivery to maintain the target temperature. This will reduce the operator's cognitive load and improve the consistency of the treatment.

Dual-Mode Needles.​ Future needles will be designed for both pulsed and thermal RF, with a single needle that can be used for either mode. This will simplify the inventory and reduce the cost.

For procurement, the recommendation is to offer both pulsed and thermal RF needles, with clear labeling and instructions. The operator should be trained on the difference between the two modes and on the appropriate clinical application.